These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 1784950)

  • 1. Effect of cyclophosphamide in active nonviral cirrhosis.
    Szanto P; Stanciu L; Togănel E; Dejica D
    Rom J Intern Med; 1991; 29(3-4):205-10. PubMed ID: 1784950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Immunoregulating phenomena in patients with alcoholic cirrhosis].
    Esparza Echevarría B; de las Heras Niño B; Solano López D; Martínez Odriozola P; de la Villa FM
    An Med Interna; 1991 Jul; 8(7):320-4. PubMed ID: 1932487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Lymphocyte subpopulations in patients with liver cirrhosis].
    Cupella F; Cirasino L; Fasani F
    Boll Ist Sieroter Milan; 1987; 66(2):145-8. PubMed ID: 2959300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase I trial of recombinant interleukin-2 and cyclophosphamide: augmentation of cellular immunity and T-cell mitogenic response with long-term administration of rIL-2.
    Kolitz JE; Wong GY; Welte K; Merluzzi VJ; Engert A; Bialas T; Polivka A; Bradley EC; Konrad M; Gnecco C
    J Biol Response Mod; 1988 Oct; 7(5):457-72. PubMed ID: 3263471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of low dose cyclophosphamide on the immune system of cancer patients: depletion of CD4+, 2H4+ suppressor-inducer T-cells.
    Berd D; Mastrangelo MJ
    Cancer Res; 1988 Mar; 48(6):1671-5. PubMed ID: 2830969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of leukocyte interleukin injection (Multikine) treatment on the peritumoral and intratumoral subpopulation of mononuclear cells and on tumor epithelia: a possible new approach to augmenting sensitivity to radiation therapy and chemotherapy in oral cancer--a multicenter phase I/II clinical Trial.
    Tímár J; Forster-Horváth C; Lukits J; Döme B; Ladányi A; Remenár E; Kásler M; Bencsik M; Répássy G; Szabó G; Velich N; Suba Z; Elõ J; Balatoni Z; Bajtai A; Chretien P; Talor E
    Laryngoscope; 2003 Dec; 113(12):2206-17. PubMed ID: 14660929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of suppressor T cell function and circulating immune complexes in alcoholic cirrhosis.
    Echevarría S; San Miguel G; Rodríguez de Lope C; Castillo E; Pons Romero F
    Allergol Immunopathol (Madr); 1985; 13(5):405-10. PubMed ID: 2934964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Bone marrow suppressor cells of patients with viral and alcoholic liver cirrhoses].
    Khaitov RM; Dzhalalova VA; Gubarev MI; Pogromov AP; Ivlev AS
    Ter Arkh; 1986; 58(1):82-6. PubMed ID: 3008363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Colchicine treatment effects on liver cirrhosis assessed by liver blood flow measurements.
    Tăpălagă D; Dumitraşcu D; Cotul S; Stanciu L; Tamaş S
    Med Interne; 1986; 24(1):69-73. PubMed ID: 3704505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of chronic diseases of the liver with catergen].
    Loginov AS; Dzhalalov KD; Blok IuE; Bendikov EA; Ausheva LKh
    Ter Arkh; 1986; 58(2):73-6. PubMed ID: 3704945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HLA, lymphocyte subsets and immunoglobulins in liver cirrhosis.
    Fiorini G; Monarca A; Natangelo R; Adelasco L; Bigi G; Paracchini ML; Renoldi P; Salomone A; Marinig C
    Quad Sclavo Diagn; 1984 Sep; 20(3):276-82. PubMed ID: 6397761
    [No Abstract]   [Full Text] [Related]  

  • 12. [Immunomodulating treatment of immunologic disorders in chronic pulmonary heart disease].
    Skakal'skaia LM
    Vrach Delo; 1980 May; (5):36-40. PubMed ID: 6967235
    [No Abstract]   [Full Text] [Related]  

  • 13. [Serum levels of IgE in liver cirrhosis].
    Cirasino L; Fasani F; Cupella F
    Boll Ist Sieroter Milan; 1987; 66(1):59-65. PubMed ID: 3497650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Phenotype study of blood T lymphocytes in alcoholic hepatopathies].
    Pelletier G; Segond P; Attali P; Briantais MJ; Etienne JP
    Gastroenterol Clin Biol; 1984 Dec; 8(12):911-4. PubMed ID: 6394417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Partial review of immunotherapeutic pharmacology in stem cell transplantation.
    Bierman PJ; Abe F; Buyukberber S; Ino K; Talmadge JE
    In Vivo; 2000; 14(1):221-36. PubMed ID: 10757081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hypergammaglobulinemia in cirrhosis. Pathogenetic aspects].
    Prytz H
    Med Chir Dig; 1979; 8(1):67-72. PubMed ID: 381798
    [No Abstract]   [Full Text] [Related]  

  • 17. A study of t cell populations in alcoholic cirrhosis and chronic alcoholism.
    Fernandez LA; Laltoo M; Fox RA
    Clin Invest Med; 1982; 5(4):241-5. PubMed ID: 6984378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomised study comparing peripheral blood progenitor mobilisation using intermediate-dose cyclophosphamide plus lenograstim with lenograstim alone.
    Karanth M; Chakrabarti S; Lovell RA; Harvey C; Holder K; McConkey CC; McDonald D; Fegan CD; Milligan DW
    Bone Marrow Transplant; 2004 Sep; 34(5):399-403. PubMed ID: 15273706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumour necrosis factor-alpha expression by activated monocytes and altered T-cell homeostasis in ascitic alcoholic cirrhosis: amelioration with norfloxacin.
    Albillos A; Hera Ad Ade L; Reyes E; Monserrat J; Muñoz L; Nieto M; Prieto A; Sanz E; Alvarez-Mon M
    J Hepatol; 2004 Apr; 40(4):624-31. PubMed ID: 15030978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymphocyte populations in chronic active liver disease: in vitro effect of levamisole on T-lymphocyte populations.
    Pozsonyi T; Fehér J; Jakab L
    Allergol Immunopathol (Madr); 1981; 9(1):37-44. PubMed ID: 6973266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.